Cargando…
The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates.
To increase the accessibility of drug-antibody complexes to tumours and to decrease non-specific binding via Fc receptors N-acetyl-melphalan (N-AcMEL) was conjugated to F(ab')2 fragments. These fragments were synthesised by pepsin degradation of IgG MoAb. Up to 20 molecules of N-AcMEL could be...
Autores principales: | Smyth, M. J., Pietersz, G. A., McKenzie, I. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001576/ https://www.ncbi.nlm.nih.gov/pubmed/3814478 |
Ejemplares similares
-
Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments
por: Casey, J L, et al.
Publicado: (1999) -
Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
por: Casey, J. L., et al.
Publicado: (1996) -
Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment
por: Obonai, Toshifumi, et al.
Publicado: (2016) -
Effects of ursolic and oleanolic on SK-MEL-2 melanoma cells: In vitro and in vivo assays
por: Caunii, Angela, et al.
Publicado: (2017) -
The tumor-inhibitory effectiveness of a novel anti-Trop2 Fab conjugate in pancreatic cancer
por: Mao, Yuan, et al.
Publicado: (2016)